Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of impaired arterial wall properties with the presence of coronary artery disease in patients with abdominal aortic aneurysms.
Rafouli-Stergiou P, Ikonomidis I, Katsiki N, Kadoglou NPE, Vlachos S, Thymis J, Parissis J, Moulakakis KG, Kakisis JD. Rafouli-Stergiou P, et al. Among authors: parissis j. J Clin Hypertens (Greenwich). 2020 Feb;22(2):187-193. doi: 10.1111/jch.13825. Epub 2020 Feb 12. J Clin Hypertens (Greenwich). 2020. PMID: 32049424 Free PMC article.
Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT, Kourea K, Panou F, Farmakis D, Paraskevaidis I, Ikonomidis I, Filippatos G, Kremastinos DT. Parissis JT, et al. Am Heart J. 2008 Apr;155(4):751.e1-7. doi: 10.1016/j.ahj.2008.01.016. Epub 2008 Mar 6. Am Heart J. 2008. PMID: 18371487 Clinical Trial.
Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Paraskevaidis IA, Bistola V, Ikonomidis I, Parissis JT, Papadopoulos C, Filippatos G, Kremastinos DT. Paraskevaidis IA, et al. Am J Cardiol. 2008 Nov 1;102(9):1225-9. doi: 10.1016/j.amjcard.2008.06.060. Epub 2008 Sep 4. Am J Cardiol. 2008. PMID: 18940297
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Lekakis J, Ikonomidis I, Papoutsi Z, Moutsatsou P, Nikolaou M, Parissis J, Kremastinos DT. Lekakis J, et al. Among authors: parissis j. Int J Cardiol. 2010 Mar 4;139(2):150-8. doi: 10.1016/j.ijcard.2008.10.010. Epub 2008 Nov 11. Int J Cardiol. 2010. PMID: 19004511 Clinical Trial.
Levosimendan: from basic science to clinical practice.
Parissis JT, Rafouli-Stergiou P, Paraskevaidis I, Mebazaa A. Parissis JT, et al. Heart Fail Rev. 2009 Dec;14(4):265-75. doi: 10.1007/s10741-008-9128-4. Epub 2008 Dec 20. Heart Fail Rev. 2009. PMID: 19101796
Effects of Darbepoetin Alfa on plasma mediators of oxidative and nitrosative stress in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Parissis JT, Kourea K, Andreadou I, Ikonomidis I, Markantonis S, Ioannidis K, Paraskevaidis I, Iliodromitis E, Filippatos G, Kremastinos DT. Parissis JT, et al. Am J Cardiol. 2009 Apr 15;103(8):1134-8. doi: 10.1016/j.amjcard.2008.12.041. Epub 2009 Feb 28. Am J Cardiol. 2009. PMID: 19361602 Clinical Trial.
Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study.
Parissis JT, Farmakis D, Nikolaou M, Birmpa D, Bistola V, Paraskevaidis I, Ikonomidis I, Gaitani S, Venetsanou K, Filippatos G, Kremastinos DT. Parissis JT, et al. Eur J Heart Fail. 2009 Oct;11(10):967-72. doi: 10.1093/eurjhf/hfp125. Eur J Heart Fail. 2009. PMID: 19789400 Free article.
406 results